Home > News > Intel charts new seas
November 21st, 2003
Intel charts new seas
For the first time, Intel Corp. has made available its chip-making nanotechnology tools to cancer researchers in the hope that being able to detect tiny defects in silicon chips also will work in human tissue to diagnose and study cancer. Though just preliminary research, Intel's union with the Fred Hutchinson Cancer Research Center in Seattle is part of a voyage toward its future beyond pure-silicon manufacturing. After all, Intel's advanced chips will be commodities within several years, say experts.
Creation of 'Rocker' protein opens way for new smart molecules in medicine, other fields December 18th, 2014
Iranian Researchers Produce Electrical Pieces Usable in Human Body December 18th, 2014
Unraveling the light of fireflies December 17th, 2014
First Home-Made Edible Herbal Nanodrug Presented to Pharmacies across Iran December 17th, 2014